(CRMZ)

Preview

This is a Preview, click here for the full commercial credit report.

ImaSight Corp. 925 Boulevard de la Carriere Suite 10 Phone: (819) 777-7979 Gatineau, QC  J8Y 6W5  Canada Ticker: LPX This company is no longer actively traded on any major stock exchange.

Business Summary ImaSight Corp., formerly Liponex Inc. (Liponex), is a development-stage, bio-pharmaceutical research company specializing in developing products related to high density lipoprotein (HDL), called good cholesterol. The Company’s primary drug candidate is CRD5, designed for the treatment and prevention of heart disease. CRD5 acts to increase the level of HDL in the blood, which stimulates the removal of low density lipoprotein (LDL) known as bad cholesterol. The Company has various other pre-clinical drug candidates in its pipeline but its primary focus is CRD5. On June 24, 2008, the business combination between ImaSight Inc. and Liponex Inc. was completed. In connection with the transaction, Liponex changed its name to ImaSight Corp.

Financial Information Financial Ratings: Z'' Score  FRISK Score Latest Financial Statements and Analyses: 3/31/2008    Annual Financials    Quarterly Financials     Current Fiscal Period: 1Q 2008 Fiscal Year End: December Last Audit: 12/31/2007 Auditors: PricewaterhouseCoopers LLP Audit Opinion: Unqualified

Industries Type Code Description Sector HEALTH Healthcare Industry BIOTRX Biotechnology & Drugs SIC 8731 Commercial Physical And Biological Research NAICS 54171 Research and Development in the Physical, Engineering, and Life Sciences

Management Title Name Age Title Date Start Date Chairman of the Board David Evans   4/5/2005 7/1/2003 President, Chief Executive Officer, Director William Dickie   4/5/2005 1/1/2005 Chief Financial Officer David Croucher 40 4/27/2005 4/27/2005 Chief Scientific Officer, Director Daniel Sparks       Corporate Secretary, Director Robert Roberts

Business Names Business Name ImaSight Corp. Liponex Inc.

General Information Number of Employees: 9 (As of 12/31/2005) Outstanding Shares: 21,758,357 (As of 5/15/2008) Stock Exchange: TSE Fax Number: (613) 822-5195 Email Address: info@imasight.com

Home | Directory | About Us | Products | Service Options | Pricing | Register | Contact Us | Testimonials | Hours of Availability | Careers | Events | Resources | Investors | Sign In
 
Copyright © by CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.
By using this website, you accept the Terms of Use Agreement.
Contact Us: 845.230.3000